Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Vanessa Gonzalez-Covarrubias"'
Autor:
Alberto Losada-García, Iván Salido-Guadarrama, Sergio Alberto Cortes-Ramirez, Marian Cruz-Burgos, Miguel Morales-Pacheco, Karla Vazquez-Santillan, Griselda Rodriguez-Martinez, Imelda González-Ramírez, Vanessa Gonzalez-Covarrubias, Carlos Perez-Plascencia, Mauricio Rodríguez-Dorantes
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 11 (2023)
Prostate cancer (PCa) ranks second in incidence and sixth in deaths globally. The treatment of patients with castration-resistant prostate cancer (CRPC) continues to be a significant clinical problem. Emerging evidence suggests that prostate cancer p
Externí odkaz:
https://doaj.org/article/a0b7dd681d7e4ad79a43278dcca13db8
Autor:
A Losada-García, SA Cortés-Ramírez, M Cruz-Burgos, M Morales-Pacheco, Carlos D Cruz-Hernández, Vanessa Gonzalez-Covarrubias, Carlos Perez-Plascencia, MA Cerbón, M Rodríguez-Dorantes
Publikováno v:
Frontiers in Genetics, Vol 12 (2022)
Neoplasic transformation is a continuous process that occurs in the body. Even before clinical signs, the immune system is capable of recognizing these aberrant cells and reacting to suppress them. However, transformed cells acquire the ability to ev
Externí odkaz:
https://doaj.org/article/87e1286f3af94de39e8fc29d6af868c1
Autor:
Marian Cruz-Burgos, Alberto Losada-Garcia, Carlos D. Cruz-Hernández, Sergio A. Cortés-Ramírez, Ignacio Camacho-Arroyo, Vanessa Gonzalez-Covarrubias, Miguel Morales-Pacheco, Samantha I. Trujillo-Bornios, Mauricio Rodríguez-Dorantes
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
The use of already-approved drugs to treat new or alternative diseases has proved to be beneficial in medicine, because it reduces both drug development costs and timelines. Most drugs can be used to treat different illnesses, due their mechanisms of
Externí odkaz:
https://doaj.org/article/dc77b545e4fe4f3595868b0363f554a5
Publikováno v:
Metabolites, Vol 12, Iss 2, p 194 (2022)
The metabolome offers a dynamic, comprehensive, and precise picture of the phenotype. Current high-throughput technologies have allowed the discovery of relevant metabolites that characterize a wide variety of human phenotypes with respect to health,
Externí odkaz:
https://doaj.org/article/56588c5354eb4c559fcbaff735874810
Autor:
Vanessa Gonzalez-Covarrubias, Marlet Morales-Franco, Omar F. Cruz-Correa, Angélica Martínez-Hernández, Humberto García-Ortíz, Francisco Barajas-Olmos, Alma Delia Genis-Mendoza, José Jaime Martínez-Magaña, Humberto Nicolini, Lorena Orozco, Xavier Soberón
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
The identification and characterization of pharmacogenetic variants in Latin American populations is still an ongoing endeavor. Here, we investigated SNVs on genes listed by the Pharmacogenomics Knowledge Base in 1284 Mestizos and 94 Natives from Mex
Externí odkaz:
https://doaj.org/article/3ce397001cdf485eb6fa9c3b2bc568ad
Autor:
Vanessa Gonzalez-Covarrubias, Javier Urena-Carrion, Beatriz Villegas-Torres, J. Eduardo Cossío-Aranda, Sergio Trevethan-Cravioto, Raul Izaguirre-Avila, O. Javier Fiscal-López, Xavier Soberon
Publikováno v:
Frontiers in Pharmacology, Vol 8 (2017)
Coumarins are widely prescribed worldwide, and in Mexico acenocumarol is the preferred form. It is well known that despite its efficacy, coumarins show a high variability for dose requirements. We investigated the pharmacogenetic variation of 110 gen
Externí odkaz:
https://doaj.org/article/7502ea4abc0345eda60231164ce555e9
Autor:
Marian Beekman, Hae-Won Uh, Diana Van Heemst, Manfred Wuhrer, L. Renee Ruhaak, Vanessa Gonzalez-Covarrubias, Thomas Hankemeier, Jeanine J. Houwing-Duistermaat, P. Eline Slagboom
Publikováno v:
Frontiers in Public Health, Vol 4 (2016)
Background: In older people chronological age may not be the best predictor of residual lifespan and mortality, because with age the heterogeneity in health is increasing. Biomarkers for biological age and residual lifespan are being developed to pre
Externí odkaz:
https://doaj.org/article/a45fe0b1d16a49f7ad157ae487b16d3f
Autor:
Tomas Texis, Susana Rivera-Mancia, Eloisa Colin-Ramirez, Raul Cartas-Rosado, David Koepsell, Kenneth Rubio-Carrasco, Mauricio Rodriguez-Dorantes, Vanessa Gonzalez-Covarrubias
Atherogenesis and dyslipidemia increase the risk of cardiovascular disease, which is the leading cause of death in developed countries. While blood lipid levels have been studied as disease predictors, their accuracy in predicting cardiovascular risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da89b9e6eee7eb6ab40bfd91f1629988
Autor:
Mauricio Rodríguez-Dorantes, Sergio Villicaña, Sergio Alberto Cortés-Ramírez, Hugo A. Barrera-Saldaña, Hector E. Sanchez-Ibarra, Fernando J. Lavalle-González, Vanessa Gonzalez-Covarrubias, Karla Lozano-Gonzalez, Xavier Soberón, Tomas Texis
Publikováno v:
Pharmacology. 106:588-596
Introduction: Genetic variants could aid in predicting antidiabetic drug response by associating them with markers of glucose control, such as glycated hemoglobin (HbA1c). However, pharmacogenetic implementation for antidiabetics is still under devel
Autor:
Tomas Texis, José Luis Cruz-Jaramilllo, Willebaldo García-Muñoz, Lourdes Anzures-Cortés, Lorenza Haddad-Talancón, Sergio Sánchez-García, María del Carmen Jiménez Martínez, Edgar Pérez Barragán, Alejandro Nieto-Patlán, José D. Martínez-Ezquerro, Kenneth Rubio-Carrasco, Mauricio Rodríguez-Dorantes, Sergio Cortés-Ramírez, Gabriela Mellado-Sánchez, Sonia Mayra Pérez-Tapia, Vanessa Gonzalez-Covarrubias
SummaryThe dissection of factors that contribute to COVID-19 infection and severity has overwhelmed the scientific community for almost 2 years. Current reports highlight the role of in disease incidence, progression, and severity. Here, we aimed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::509ffd0244686bde1d9a692925b7f868
https://doi.org/10.1101/2022.04.15.22273925
https://doi.org/10.1101/2022.04.15.22273925